Not medical advice. This site is general information only. In an emergency call your local emergency number. For advice about your own health, speak to a doctor, pharmacist or other qualified health professional.
Semaglutide
About Semaglutide
A GLP 1 receptor agonist that has transformed obesity treatment. Semaglutide or Ozempic treats type 2 diabetes and, at higher doses, is approved as Wegovy for weight loss. It stimulates insulin release, slows stomach emptying, and reduces appetite. In trials, semaglutide produced average weight loss of about 15 percent, approaching results from bariatric surgery. Its long half life permits infrequent injections, and an oral form also exists. Shortages occurred due to massive demand. The drug has sparked cultural conversations about obesity as a medical condition.